Racial differences in clinically localized prostate cancers of black and white men

Ralph W. DeVere White, Arline D. Deitch, Aaron G. Jackson, Regina Gandour-Edwards, Josephine Marshalleck, Stephanie E. Soares, Salvador N. Toscano, Jennine M. Lunetta, Susan Leroy Stewart

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Purpose: Tumor grade, deoxyribonucleic acid (DNA) ploidy, proliferation, p53 and bcl-2 expression were examined in clinically localized prostate cancers of black and white American men to learn whether these features showed racial differences. Materials and Methods: A total of 117 prostate cancers (43 black and 74 white patients) obtained at radical prostatectomy for clinically localized disease were assigned Gleason scores by a single pathologist. Enzymatically dissociated nuclei from archival prostate cancers were examined by DNA flow cytometry using propidium iodide staining and the multicycle program to remove debris and sliced nuclei and to perform cell cycle analysis. For immunostaining after microwave antigen retrieval we used a DO-1/DO-7 monoclonal antibody cocktail for p53 and the clone 124 antibody for bcl-2. Results: Significantly more black than white men had Gleason score 7 tumors. The DNA ploidy distribution of Gleason 6 or less tumors was similar for both races. As anticipated, the ploidy distribution of higher grade prostate cancer in white men was more abnormal but, unexpectedly, this was not found for higher grade prostate cancer in black men. No significant racial differences were found in S phase fractions, p53 or bcl-2 immunopositivity. However, for prostate cancer in black men there was a significant association between bcl-2 immunopositivity and higher S-phase fractions. Conclusions: The aggressive prostate cancers of black men may be characterized by the 2 features of high proliferation and a block to programmed cell death.

Original languageEnglish (US)
Pages (from-to)1979-1983
Number of pages5
JournalJournal of Urology
Volume159
Issue number6
StatePublished - Jun 1998

Fingerprint

Prostatic Neoplasms
Ploidies
Neoplasm Grading
S Phase
DNA
Neoplasms
Propidium
Prostatectomy
Microwaves
hydroquinone
Cell Cycle
Flow Cytometry
Cell Death
Clone Cells
Staining and Labeling
Antigens
Antibodies

Keywords

  • Ethnic groups
  • Genes
  • P53
  • Prostatic neoplasms
  • S phase

ASJC Scopus subject areas

  • Urology

Cite this

Racial differences in clinically localized prostate cancers of black and white men. / DeVere White, Ralph W.; Deitch, Arline D.; Jackson, Aaron G.; Gandour-Edwards, Regina; Marshalleck, Josephine; Soares, Stephanie E.; Toscano, Salvador N.; Lunetta, Jennine M.; Stewart, Susan Leroy.

In: Journal of Urology, Vol. 159, No. 6, 06.1998, p. 1979-1983.

Research output: Contribution to journalArticle

DeVere White, RW, Deitch, AD, Jackson, AG, Gandour-Edwards, R, Marshalleck, J, Soares, SE, Toscano, SN, Lunetta, JM & Stewart, SL 1998, 'Racial differences in clinically localized prostate cancers of black and white men', Journal of Urology, vol. 159, no. 6, pp. 1979-1983.
DeVere White, Ralph W. ; Deitch, Arline D. ; Jackson, Aaron G. ; Gandour-Edwards, Regina ; Marshalleck, Josephine ; Soares, Stephanie E. ; Toscano, Salvador N. ; Lunetta, Jennine M. ; Stewart, Susan Leroy. / Racial differences in clinically localized prostate cancers of black and white men. In: Journal of Urology. 1998 ; Vol. 159, No. 6. pp. 1979-1983.
@article{6f308b2712904bf5bdab8ea6122f51e0,
title = "Racial differences in clinically localized prostate cancers of black and white men",
abstract = "Purpose: Tumor grade, deoxyribonucleic acid (DNA) ploidy, proliferation, p53 and bcl-2 expression were examined in clinically localized prostate cancers of black and white American men to learn whether these features showed racial differences. Materials and Methods: A total of 117 prostate cancers (43 black and 74 white patients) obtained at radical prostatectomy for clinically localized disease were assigned Gleason scores by a single pathologist. Enzymatically dissociated nuclei from archival prostate cancers were examined by DNA flow cytometry using propidium iodide staining and the multicycle program to remove debris and sliced nuclei and to perform cell cycle analysis. For immunostaining after microwave antigen retrieval we used a DO-1/DO-7 monoclonal antibody cocktail for p53 and the clone 124 antibody for bcl-2. Results: Significantly more black than white men had Gleason score 7 tumors. The DNA ploidy distribution of Gleason 6 or less tumors was similar for both races. As anticipated, the ploidy distribution of higher grade prostate cancer in white men was more abnormal but, unexpectedly, this was not found for higher grade prostate cancer in black men. No significant racial differences were found in S phase fractions, p53 or bcl-2 immunopositivity. However, for prostate cancer in black men there was a significant association between bcl-2 immunopositivity and higher S-phase fractions. Conclusions: The aggressive prostate cancers of black men may be characterized by the 2 features of high proliferation and a block to programmed cell death.",
keywords = "Ethnic groups, Genes, P53, Prostatic neoplasms, S phase",
author = "{DeVere White}, {Ralph W.} and Deitch, {Arline D.} and Jackson, {Aaron G.} and Regina Gandour-Edwards and Josephine Marshalleck and Soares, {Stephanie E.} and Toscano, {Salvador N.} and Lunetta, {Jennine M.} and Stewart, {Susan Leroy}",
year = "1998",
month = "6",
language = "English (US)",
volume = "159",
pages = "1979--1983",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Racial differences in clinically localized prostate cancers of black and white men

AU - DeVere White, Ralph W.

AU - Deitch, Arline D.

AU - Jackson, Aaron G.

AU - Gandour-Edwards, Regina

AU - Marshalleck, Josephine

AU - Soares, Stephanie E.

AU - Toscano, Salvador N.

AU - Lunetta, Jennine M.

AU - Stewart, Susan Leroy

PY - 1998/6

Y1 - 1998/6

N2 - Purpose: Tumor grade, deoxyribonucleic acid (DNA) ploidy, proliferation, p53 and bcl-2 expression were examined in clinically localized prostate cancers of black and white American men to learn whether these features showed racial differences. Materials and Methods: A total of 117 prostate cancers (43 black and 74 white patients) obtained at radical prostatectomy for clinically localized disease were assigned Gleason scores by a single pathologist. Enzymatically dissociated nuclei from archival prostate cancers were examined by DNA flow cytometry using propidium iodide staining and the multicycle program to remove debris and sliced nuclei and to perform cell cycle analysis. For immunostaining after microwave antigen retrieval we used a DO-1/DO-7 monoclonal antibody cocktail for p53 and the clone 124 antibody for bcl-2. Results: Significantly more black than white men had Gleason score 7 tumors. The DNA ploidy distribution of Gleason 6 or less tumors was similar for both races. As anticipated, the ploidy distribution of higher grade prostate cancer in white men was more abnormal but, unexpectedly, this was not found for higher grade prostate cancer in black men. No significant racial differences were found in S phase fractions, p53 or bcl-2 immunopositivity. However, for prostate cancer in black men there was a significant association between bcl-2 immunopositivity and higher S-phase fractions. Conclusions: The aggressive prostate cancers of black men may be characterized by the 2 features of high proliferation and a block to programmed cell death.

AB - Purpose: Tumor grade, deoxyribonucleic acid (DNA) ploidy, proliferation, p53 and bcl-2 expression were examined in clinically localized prostate cancers of black and white American men to learn whether these features showed racial differences. Materials and Methods: A total of 117 prostate cancers (43 black and 74 white patients) obtained at radical prostatectomy for clinically localized disease were assigned Gleason scores by a single pathologist. Enzymatically dissociated nuclei from archival prostate cancers were examined by DNA flow cytometry using propidium iodide staining and the multicycle program to remove debris and sliced nuclei and to perform cell cycle analysis. For immunostaining after microwave antigen retrieval we used a DO-1/DO-7 monoclonal antibody cocktail for p53 and the clone 124 antibody for bcl-2. Results: Significantly more black than white men had Gleason score 7 tumors. The DNA ploidy distribution of Gleason 6 or less tumors was similar for both races. As anticipated, the ploidy distribution of higher grade prostate cancer in white men was more abnormal but, unexpectedly, this was not found for higher grade prostate cancer in black men. No significant racial differences were found in S phase fractions, p53 or bcl-2 immunopositivity. However, for prostate cancer in black men there was a significant association between bcl-2 immunopositivity and higher S-phase fractions. Conclusions: The aggressive prostate cancers of black men may be characterized by the 2 features of high proliferation and a block to programmed cell death.

KW - Ethnic groups

KW - Genes

KW - P53

KW - Prostatic neoplasms

KW - S phase

UR - http://www.scopus.com/inward/record.url?scp=0032424488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032424488&partnerID=8YFLogxK

M3 - Article

C2 - 9598502

AN - SCOPUS:0032424488

VL - 159

SP - 1979

EP - 1983

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -